Fortis Healthcare has announced it has received an in-principle approval from the board to acquire 86% in Super Religare Laboratories (SRL). However, there are a lot of unanswered questions reports CNBC-TV18's Nayantara Rai.
first published: Apr 15, 2011 09:53 am
A collection of the most-viewed Moneycontrol videos.
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
LIVE: RBI Governor Sanjay Malhotra Delivers Key Monetary Policy Statement | Interest Rates & Outlook
Nifty’s Move Hinges On RBI Rate Decision; HUL, ITC Hotels In Focus| Opening Bell Live
Nifty Sideways But Holds 26,000 Ahead Of MPC Rate Decision| IT & Realty Upbeat| Closing Bell Live
